Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel: +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:

Copyright/Disclaimer

New DDDs 2012

New ATC codes 2012
ATC/DDD alterations 2012

ATC code	ATC level name	New DDD

A03AE04	prucalopride	2	mg	O
A16AB10	velaglucerase alfa	300	U	P
B01AC24	ticagrelor	0.18	g	O
B02BX05	eltrombopag	50	mg	O
B06AC04	conestat alfa	3.5	TU	P
C01BG11	vernakalant	0.2	g	P
G03DB08	dienogest	2	mg	O
G03GA09	corifollitropin alfa	0.15	mg	P
H01CA03	histrelin	0.137	mg ¹⁾	implant
J01CA19	aspoxicillin	4	g	P
J01DC12	cefminox	4	g	P
J01DC13	cefbuperazone	2	g	P
J01DC14	flomoxef	2	g	P
J01DF01	aztreonam	0.225	g	Inhal. solution
J01DF02	carumonam	2	g	P
J01GB10	ribostamycin	1	g	P
J01GB11	isepamicin	0.4	g	P
J01GB13	bekanamycin	0.6	g	P
L03AX15	mifamurtide	0.7	mg	P
L04AA27	fingolimod	0.5	mg	O
M01AB51	indometacin, combinations	0.1	g ²⁾	O,R
N02AX06	tapentadol	0.4	g	O
N02BG07	flupirtine	0.4	g	O
N05AH05	asenapine	20	mg	O
N06AX23	desvenlafaxine	50	mg	O
N07XX07	fampridine	20	mg	O
R03AC18	indacaterol	0.15	mg	Inhal. powder
R03DX07	roflumilast	0.5	mg	O

1) DDD assigned according to the total content of the implant
2) refers to indometacin

Last updated: 2011-11-24